Nuclear adenomatous polyposis coli suppresses colitis-associated tumorigenesis in mice

Carcinogenesis

Volumn 35, Issue 8, 2014, Pages 1881-1890

  Zeineldin, Maged ^a   Miller, Matthew A ^a   Sullivan, Ruth ^b   Neufeld, Kristi L ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Adenomatous polyposis coli (APC); Colitis; Goblet cell differentiation; Mouse model; Tumorigenesis

Indexed keywords

AZOXYMETHANE; BETA CATENIN; DEXTRAN SULFATE; K RAS PROTEIN; APC PROTEIN; CARCINOGEN; CYCLOOXYGENASE 2; MESSENGER RNA; PTGS2 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER SUSCEPTIBILITY; CELL COUNT; CELL PROLIFERATION; CHRONIC INFLAMMATION; COLITIS; COLON ADENOMA; COLON CARCINOGENESIS; COLON POLYPOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; EDEMA; GENE MUTATION; HISTOPATHOLOGY; LYMPH FOLLICLE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; WEIGHT REDUCTION; ANIMAL; CELL NUCLEUS; CELL TRANSFORMATION; CHEMICALLY INDUCED; COLORECTAL NEOPLASMS; COMPLICATION; DISEASE MODEL; GENETICS; INFLAMMATION; METABOLISM; MUTATION; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; APOPTOSIS; AZOXYMETHANE; BETA CATENIN; BLOTTING, WESTERN; CARCINOGENS; CELL NUCLEUS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COLITIS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; INFLAMMATION; MICE; MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84905674529     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu121     Document Type: Article

References (48)

1. Terzic, J., et al. (2010) Inflammation and colon cancer. Gastroenterology, 138, 2101-2114 e5.
2. Din, F.V., et al. (2010) Effect of aspirin and NSAIDs on risk and survival from colorectal cancer. Gut, 59, 1670-9.
3. Rowland, K.J., et al. (2013) The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis. Semin Pediatr Surg, 22, 101-11.
4. Borrello, M.G., et al. (2008) Inflammation and cancer: the oncogene-driven connection. Cancer Lett, 267, 262-70.
5. Camilleri, M., et al. (2012) Intestinal barrier function in health and gastrointestinal disease (vol 24, pg 503, 2012). Neurogastroenterology and Motility, 24, 976-976.
6. Pastorelli, L., et al. (2013) Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation: Lessons Learned from Animal Models and Human Genetics. Front Immunol, 4, 280.
7. Dorofeyev, A.E., et al. (2013) Mucosal barrier in ulcerative colitis and Crohn's disease. Gastroenterol Res Pract, 2013, 431231.
8. Heazlewood, C.K., et al. (2008) Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. Plos Medicine, 5, 440-460.
9. Ricci-Vitiani, L., et al. (2009) Colon cancer stem cells. J Mol Med, 87, 1097- 104.
10. Neufeld, K.L., et al. (1997) Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein. Proc Natl Acad Sci U S A, 94, 3034-9.
11. Polakis, P. (2000) Wnt signaling and cancer. Genes Dev, 14, 1837-51.
12. Neufeld, K.L. (2009) Nuclear APC. Adv Exp Med Biol, 656, 13-29.
13. Rosin-Arbesfeld, R., et al. (2000) The APC tumour suppressor has a nuclear export function. Nature, 406, 1009-12.
14. Anderson, C.B., et al. (2002) Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon. Proc Natl Acad Sci U S A, 99, 8683- 8.
15. Henderson, B.R. (2000) Nuclear-cytoplasmic shuttling of APC regulates betacatenin subcellular localization and turnover. Nat Cell Biol, 2, 653-60.
16. Wang, Y., et al. (2008) Interaction between Tumor Suppressor Adenomatous Polyposis Coli and Topoisomerase II{alpha}: Implication for the G2/M Transition. Mol. Biol. Cell, 19, 4076-4085.
17. Jaiswal, A.S., et al. (2008) A novel function of adenomatous polyposis coli (APC) in regulating DNA repair. Cancer Lett, 271, 272-80.
18. Qian, J., et al. (2008) The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus. Gastroenterology, 135, 152-62.
19. Zeineldin, M., et al. (2012) A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression. Oncogene, 31, 2423-37.
20. Takahashi, M., et al. (2004) Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci, 95, 475- 80.
21. Zeineldin, M., et al. (2013) Understanding phenotypic variation in rodent models with germline apc mutations. Cancer Res, 73, 2389-99.
22. Zeineldin, M., et al. (2013) More than two decades of Apc modeling in rodents. Biochim Biophys Acta, 1836, 80-89.
23. Takahashi, M., et al. (2000) Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis, 21, 1117-20.
24. Cooper, H.S., et al. (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest, 69, 238-49.
25. Zeineldin, M., et al. (2012) Isolation of Epithelial Cells from Mouse Gastrointestinal Tract for Western Blot or RNA analysis solation of Epithelial Cells from Mouse Gastrointestinal Tract for Western Blot or RNA analysis
26. Cooper, H.S., et al. (2000) Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis, 21, 757-68.
27. Rencher, A.C., et al. (2008) Methods of Multivariate Analysis, 3rd Edition. Wiley.
28. Tan, C.W., et al. (2013) Colon cryptogenesis: asymmetric budding. PLoS One, 8, e78519.
29. Dekaney, C.M., et al. (2009) Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice. Am J Physiol Gastrointest Liver Physiol, 297, G461-70.
30. Barker, N., et al. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature, 457, 608-11.
31. Grivennikov, S.I., et al. (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature, 491, 254-8.
32. Chen, L.C., et al. (2004) Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients. Cancer Res, 64, 3694-700.
33. Clapper, M.L., et al. (2007) Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin, 28, 1450-9.
34. Dennis, K.L., et al. (2013) Adenomatous Polyps Are Driven by Microbe- Instigated Focal Inflammation and Are Controlled by IL-10-Producing T Cells. Cancer Res, 73, 5905-13.
35. Haertel-Wiesmann, M., et al. (2000) Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J Biol Chem, 275, 32046-51.
36. Howe, L.R., et al. (1999) Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res, 59, 1572-7.
37. Longo, K.A., et al. (2002) Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem, 277, 38239-44.
38. Harris, R.E. (2009) Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology, 17, 55-67.
39. Yoshimi, K., et al. (2013) Tumor suppressor APC protein is essential in mucosal repair from colonic inflammation through angiogenesis. Am J Pathol, 182, 1263-74.
40. Neufeld, K.L., et al. (2000) Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc Natl Acad Sci U S A, 97, 12085-90.
41. Leow, C.C., et al. (2005) A role for Hath1, a bHLH transcription factor, in colon adenocarcinoma. Ann N Y Acad Sci, 1059, 174-83.
42. Eisinger, A.L., et al. (2006) The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid. J Biol Chem, 281, 20474-82.
43. Castellone, M.D., et al. (2005) Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science, 310, 1504-10.
44. Du, Q., et al. (2006) Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling. Cancer Res, 66, 7024-31.
45. Half, E., et al. (2009) Colon cancer: preventive agents and the present status of chemoprevention. Expert Opin Pharmacother, 10, 211-9.
46. Tessner, T.G., et al. (2004) Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation. J Clin Invest, 114, 1676-85.
47. Jones, M.K., et al. (1999) Inhibition of angiogenesis by nonsteroidal antiinflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med, 5, 1418-23.
48. Khayrullina, T., et al. (2008) In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J Immunol, 181, 721-35.